Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice

Journal of Neuroscience Research

Volumn 85, Issue 11, 2007, Pages 2433-2440

  Saleem, Sofiyan ^a   Li, Rung Chi ^a   Wei, Guo ^a   Doré, Sylvain ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain ischemia; Neuroprotection; Oxidative stress; Prostanoid; SC 51089

Indexed keywords

IODOPHENAZONE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; SC 51089; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; AUTORADIOGRAPHY; BLOOD GAS; BLOOD PH; BLOOD VESSEL TONE; BODY TEMPERATURE; BRAIN BLOOD FLOW; CELL DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG MECHANISM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; BRAIN; CELL SURVIVAL; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; FEMALE; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE; MICE, KNOCKOUT; NEURONS; RECEPTORS, PROSTAGLANDIN E; STROKE;

EID: 34547625217     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21399     Document Type: Article

References (32)

1. Ahmad AS, Saleem S, Ahmad M, Dore S. 2006. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 89:265-270.
2. Audoly LP, Tilley SL, Goulet J, Key M, Nguyen M, Stock JL, McNeish JD, Roller BH, Coffman TM. 1999. Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. Am J Physiol 277:H924-930.
3. Davis RJ, Murdoch CE, Ali M, Purbrick S, Ravid R, Baxter GS, Tilford N, Sheldrick RL, Clark KL, Coleman RA. 2004. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol 141:580-585.
4. Doré S, Otsuka T, Mito T, Sugo N, Hand T, Wu L, Hum PD, Traystman RJ, Andreasson K. 2003. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann Neurol 54:155-162.
5. 2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following b-amyloid exposure. Eur J Neurosci 22:2199-2206.
6. Funk CD, Furci L, FitzGerald GA, Grygorczyk R, Rochette C, Bayne MA, Abramovitz M, Adam M, Metters KM. 1993. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem 268:26767-26772.
7. Gendron TF, Brunette E, Tauskela JS, Morley P. 2005. The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection. Eur J Pharmacol 517:17-27.
8. Guay J, Bateman K, Gordon R, Mancini J, Riendeau D. 2004. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem 279:24866-24872.
9. Jadhav V, Jabre A, Lin SZ, Lee TJ. 2004. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries. J Cereb Blood Flow Metab 24:1305-1316.
10. Jay TM, Lucignani G, Crane AM, Jehle J, Sokoloff L. 1988. Measurement of local cerebral blood flow with [14C]iodoantipyrine in the mouse. J Cereb Blood Flow Metab 8:121-129.
11. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C. 2006. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12:225-229.
12. Kirkness CJ. 2005. Cerebral blood flow monitoring in clinical practice. AACN Clin Issues 16:476-487.
13. Li DY, Abran D, Peri KG, Varma DR, Chemtob S. 1996. Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels. J Pharmacol Exp Ther 278:370-377.
14. Li DY, Hardy P, Abran D, Martinez-Bermudez AK, Guerguerian AM, Bhattacharya M, Almazan G, Menezes R, Peri KG, Varma DR, Chemtob S. 1997. Key role for cyclooxygenase-2 in PGE2 and PGF2alpha receptor regulation and cerebral blood flow of the newborn. Am J Physiol 273:R1283-1290.
15. Littlejohns L, Bader MK. 2005. Prevention of secondary brain injury: targeting technology. AACN Clin Issues 16:501-514.
16. Liu J, Simpson DM, Allen R. 2005. High spontaneous fluctuation in arterial blood pressure improves the assessment of cerebral autoregulation. Physiol Meas 26:725-741.
17. Nakayama Y, Omote K, Kawamata T, Namiki A. 2004. Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn. Brain Res 1010:62-68.
18. Narumiya S, FitzGerald GA. 2001. Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108:25-30.
19. Narumiya S, Sugimoto Y, Ushikubi F. 1999. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226.
20. Norel X, de Montpreville V, Brink C. 2004. Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713. Prostaglandins Other Lipid Mediat 74:101-112.
21. Oka T. 2004. Prostaglandin E2 as a mediator of fever: the role of prostaglandin E (EP) receptors. Front Biosci 9:3046-3057.
22. Rocca B. 2006. Targeting PGE2 receptor subtypes rather than cyclooxygenases: a bridge over troubled water? Mol Interv 6:68-73.
23. Sampei K, Goto S, Alkayed NJ, Crain BJ, Korach KS, Traystman RJ, Demas GE, Nelson RJ, Hurn PD. 2000. Stroke in estrogen receptor-alpha-deficient mice. Stroke 31:738-743; discussion 744.
24. Sawada M, Alkayed NJ, Goto S, Crain BJ, Traystman RJ, Shaivitz A, Nelson RJ, Hurn PD. 2000. Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. J Cereb Blood Flow Metab 20:112-118.
25. Schweda F, Kurtz A. 2004. Cellular mechanism of renin release. Acta Physiol Scand 181:383-390.
26. Stock JL, Shinjo K, Burkhardt J, Roach M, Taniguchi K, Ishikawa T, Kim HS, Flannery PJ, Cofffman TM, McNeish JD, Audoly LP. 2001. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J Clin Invest 107:325-331.
27. Suganami T, Mori K, Tanaka I, Mukoyama M, Sugawara A, Makino H, Muro S, Yahata K, Ohuchida S, Maruyama T, Narumiya S, Nakao K. 2003. Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats. Hypertension 42:1183-1190.
28. Watabe A, Sugimoto Y, Honda A, Irie A, Namba T, Negishi M, Ito S, Narumiya S, Ichikawa A. 1993. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem 268:20175-20178.
29. Wong D, Wang M, Cheng Y, Fitzgerald GA. 2005. Cardiovascular hazard and non-steroidal anti-inflammatory drugs. Curr Opin Pharmacol 5:204-210.
30. Zhang Y, Guan Y, Schneider A, Brandon S, Breyer RM, Breyer MD. 2000. Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors. Hypertension 35:1129-1134.
31. Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T, Carmignoto G. 2003a. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6:43-50.
32. Zonta M, Sebelin A, Gobbo S, Fellin T, Pozzan T, Carmignoto G. 2003b. Glutamate-mediated cytosolic calcium oscillations regulate a pulsatile prostaglandin release from cultured rat astrocytes. J Physiol 553:407-414.